Heterocyclic compounds; containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fused, levorphanol (INN) and its salts

HS v2017 Code: 293341

About heterocyclic compounds; containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fused, levorphanol (inn) and its salts

HS code 293341 covers a group of heterocyclic organic compounds that contain a quinoline or isoquinoline ring system. These compounds are widely used in the pharmaceutical industry, particularly in the production of certain types of analgesics and other medications. The global market for these compounds is significant, with applications across various therapeutic areas and a growing demand driven by an aging population and the need for effective pain management solutions.

Production process

The production of compounds under HS code 293341 typically involves a multi-step organic synthesis process. This may include the cyclization of appropriate precursor molecules, the introduction of the quinoline or isoquinoline ring system, and various purification and isolation steps to obtain the desired final product. The specific techniques used can vary depending on the target compound and the manufacturing facility, but often involve the use of specialized equipment, precise temperature and pressure control, and careful monitoring of reaction conditions.

Production inputs

The main inputs required for the production of compounds under HS code 293341 include a range of organic chemicals, such as aromatic amines, aldehydes, and ketones, as well as various solvents, catalysts, and other reagents. Additionally, specialized laboratory equipment, such as reaction vessels, distillation columns, and analytical instruments, are essential for the synthesis and purification of these heterocyclic compounds. The availability and quality of these inputs can significantly impact the efficiency and cost-effectiveness of the production process.

Production outputs

The primary outputs of the industry covered by HS code 293341 are the heterocyclic compounds themselves, which are then used as intermediates or active pharmaceutical ingredients (APIs) in the production of various medications. These compounds may be further processed or combined with other substances to create finished pharmaceutical products, such as 300490 Medicaments; consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses or in forms or packings for retail sale, 300220 Vaccines, for human medicine, and 300290 Vaccines, for veterinary medicine.

Revisions to 293341

Classification codes are adjusted frequently. The code may have been revised or replaced between system versions. The table below shows the history (newest to oldest) of the code 293341. The most recent 1 version of this code (293341) is in the HS v2022 system:

This page shows a legacy version of code 293341 ( HS v2017).

Family tree for heterocyclic compounds; containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fused, levorphanol (inn) and its salts

    graph LR
    A["<a href='/classifications/hs/v2017/29'>29: Organic chemicals</a>"]
A --> B["<a href='/classifications/hs/v2017/2933'>2933: Heterocyclic compounds with nitrogen hetero-atom(s) only</a>"]
B --> C["<a href='/classifications/hs/v2017/293341'>293341: Heterocyclic compounds; containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fused, levorphanol (INN) and its salts</a>"]

    B --> D["<a href='/classifications/hs/v2017/293311'>293311: Heterocyclic compounds; with nitrogen hetero-atom(s) only, containing an unfused pyrazole ring (whether or not hydrogenated) in the structure, phenazone (antipyrin) and its derivatives</a>"]
B --> E["<a href='/classifications/hs/v2017/293319'>293319: Heterocyclic compounds; with nitrogen hetero-atom(s) only, containing an unfused pyrazole ring (whether or not hydrogenated) in the structure, other than henazone (antipyrin) and its derivatives</a>"]
B --> F["<a href='/classifications/hs/v2017/293321'>293321: Heterocyclic compounds; with nitrogen hetero-atom(s) only, containing an unfused imidazole ring (whether or not hydrogenated) in the structure, hydantoin and its derivatives</a>"]
B --> G["<a href='/classifications/hs/v2017/293329'>293329: Heterocyclic compounds; with nitrogen hetero-atom(s) only, containing an unfused imidazole ring (whether or not hydrogenated) in the structure, other than hydantoin and its derivatives</a>"]
B --> H["<a href='/classifications/hs/v2017/293331'>293331: Heterocyclic compounds; containing an unfused pyridine ring (whether or not hydrogenated) in the structure, pyridine and its salts</a>"]
B --> I["<a href='/classifications/hs/v2017/293332'>293332: Heterocyclic compounds; containing an unfused pyridine ring (whether or not hydrogenated) in the structure, piperidine and its salts</a>"]
B --> J["<a href='/classifications/hs/v2017/293333'>293333: Heterocyclic compounds; containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts, other than piperidine and its salts</a>"]
B --> K["<a href='/classifications/hs/v2017/293339'>293339: Heterocyclic compounds; containing an unfused pyridine ring (whether or not hydrogenated) in the structure, n.e.c. in 2933.3</a>"]
B --> L["<a href='/classifications/hs/v2017/293349'>293349: Heterocyclic compounds; containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fused, other than levorphanol (INN) and its salts</a>"]
B --> M["<a href='/classifications/hs/v2017/293352'>293352: Heterocyclic compounds; containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, malonylurea (barbituric acid) and its salts</a>"]
B --> N["<a href='/classifications/hs/v2017/293353'>293353: Allobarbital (INN), amobarbital (INN), barbital (INN), butalbital (INN), butobarbital, cyclobarbital (INN), methylphenobarbital (INN), pentobarbital (INN), phenobarbital (INN), secbutabarbital (INN), secobarbital (INN) and vinylbital (INN); salts thereof</a>"]
B --> O["<a href='/classifications/hs/v2017/293354'>293354: Heterocyclic compounds; containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, other derivatives of malonylurea (barbituric acid) and salts thereof, n.e.c. in 2933.53</a>"]
B --> P["<a href='/classifications/hs/v2017/293355'>293355: Heterocyclic compounds; containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure; loprazolam (INN), mecloqualone (INN), methaqualone (INN), and zipeprol (INN); salts thereof</a>"]
B --> Q["<a href='/classifications/hs/v2017/293359'>293359: Heterocyclic compounds; containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea and its derivatives, loprazolam, mecloqualone, methaqualone, zipeprol, and salts thereof) n.e.c. in 2933.5</a>"]
B --> R["<a href='/classifications/hs/v2017/293361'>293361: Heterocyclic compounds; containing an unfused triazine ring (whether or not hydrogenated) in the structure, melamine</a>"]
B --> S["<a href='/classifications/hs/v2017/293369'>293369: Heterocyclic compounds; containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamine</a>"]
B --> T["<a href='/classifications/hs/v2017/293371'>293371: Heterocyclic compounds; lactams; 6-hexanelactam (epsilon-caprolactam)</a>"]
B --> U["<a href='/classifications/hs/v2017/293372'>293372: Heterocyclic compounds; lactams; clobazam (INN) and methyprylon (INN)</a>"]
B --> V["<a href='/classifications/hs/v2017/293379'>293379: Heterocyclic compounds; lactams; other than 6-hexanelactam (epsilon caprolactam) and clobazam (INN) and methyprylon (INN)</a>"]
B --> W["<a href='/classifications/hs/v2017/293391'>293391: Heterocyclic compounds; alprazolam (INN), camazepam (INN), chlordiazepoxide (INN), clonazepam (INN), clorazepate, delorazepam (INN), diazepam (INN), estazolam (INN), ethyl loflazepate (INN), fludiazepam (INN), flunitrazepam (INN), (cont)</a>"]
B --> X["<a href='/classifications/hs/v2017/293392'>293392: Heterocyclic compounds; azinphos-methyl (ISO)</a>"]
B --> Y["<a href='/classifications/hs/v2017/293399'>293399: Heterocyclic compounds; n.e.c. in headings no. 2933</a>"]

    

    %% Color coordination by level

    classDef level1 color:#000,fill:#a8f9ff,stroke:#333,stroke-width:2px
    classDef level2 color:#000,fill:#e0a458,stroke:#333,stroke-width:1px
    classDef level3 color:#000,fill:#419d78,stroke:#333,stroke-width:1px
    classDef level4 color:#000,fill:#c04abc,stroke:#333,stroke-width:1px
    classDef level5 color:#000,fill:#f1c40f,stroke:#333,stroke-width:1px
    classDef level6 color:#000,fill:#f1c40f,stroke:#333,stroke-width:1px
    classDef highlight color:#000,fill:#fff,stroke:#000,stroke-width:5px



  %% Apply classes
  class A level2
class B level4
class C level6
class D level6
class E level6
class F level6
class G level6
class H level6
class I level6
class J level6
class K level6
class L level6
class M level6
class N level6
class O level6
class P level6
class Q level6
class R level6
class S level6
class T level6
class U level6
class V level6
class W level6
class X level6
class Y level6

  class C highlight

  %% class A level1
  %% class B,C level2
  %% class D,E,F,G,H,I level2
  %% class J,K,L,M,N,O,P level3
  %% class C highlight